Impact of Real-time Automatic Quality Control System on Colorectal Adenoma Detection
1 other identifier
interventional
1,254
1 country
6
Brief Summary
The purpose of this study was to assess the performance of automatic quality-control system (AQCS) in real-time quality control of colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Shorter than P25 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2021
CompletedFirst Posted
Study publicly available on registry
May 25, 2021
CompletedStudy Start
First participant enrolled
May 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2022
CompletedMay 25, 2021
May 1, 2021
7 months
May 24, 2021
May 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colorectal adenoma detection rate (ADR)
The primary endpoint is the adenoma detection rate (ADR), which is the proportion of patients having one or more adenomas detected by colonoscopy.
10 months
Secondary Outcomes (4)
Colorectal polyp detection rate (PDR)
10 months
The mean number of adenomas detected per colonoscopy (APC)
10 months
The mean number of polyps detected per colonoscopy (PPC)
10months
Withdrawl time
During procedure
Study Arms (2)
AQCS-aided group
EXPERIMENTALPatients in AQCS-aided group will go through colonoscopy examination with the assitance of AQCS.
Control group
NO INTERVENTIONPatients in control group will go through conventional standard colonoscopy examination without the assistance of the AQCS.
Interventions
Automatic quality-control system(AQCS), developed based on deep convolutional neural network (DCNN) models, could improve the colonoscopists' performance during withdrawal phase and significantly increase polyp and adenoma detection.
Eligibility Criteria
You may qualify if:
- Consecutive patients (aged 18-80 years) scheduled for colonoscopy examination.
You may not qualify if:
- Patients with a history of inflammatory bowel disease, advanced colorectal cancer, polyposis syndromes or known colorectal polyps without complete removal previously.
- Patients with a history of colorectal surgery.
- Patients with a contraindication for biopsy.
- Patients with prior failed colonoscopy.
- Patients with known stenosis or obstruction.
- Patients in pregnancy or lactation phase.
- Patients refused to participate in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shandong Universitylead
- Binzhou Medical Universitycollaborator
- Shengli Oilfield Hospitalcollaborator
- Linyi People's Hospitalcollaborator
- Zibo Municipal Hospitalcollaborator
- The People's Hospital of Zhaoyuan Citycollaborator
Study Sites (6)
Binzhou Medical University Hospital
Binzhou, Shandong, China
Linyi People's Hospital
Dezhou, Shandong, China
Central Hospital of Shengli Oilfield
Dongying, Shandong, China
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
The People's Hospital of Zhaoyuan City
Yantai, Shandong, China
Zibo Municipal Hospital
Zibo, Shandong, China
Related Publications (1)
Liu J, Zhou R, Liu C, Liu H, Cui Z, Guo Z, Zhao W, Zhong X, Zhang X, Li J, Wang S, Xing L, Zhao Y, Ma R, Ni J, Li Z, Li Y, Zuo X. Automatic Quality Control System and Adenoma Detection Rates During Routine Colonoscopy: A Randomized Clinical Trial. JAMA Netw Open. 2025 Jan 2;8(1):e2457241. doi: 10.1001/jamanetworkopen.2024.57241.
PMID: 39883463DERIVED
Study Officials
- STUDY CHAIR
Yanqing Li, PhD
Qilu Hospital of Shandong University
- STUDY CHAIR
Xiuli Zuo, PhD
Qilu Hospital of Shandong University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice president of Qilu Hospital
Study Record Dates
First Submitted
May 24, 2021
First Posted
May 25, 2021
Study Start
May 27, 2021
Primary Completion
January 1, 2022
Study Completion
January 31, 2022
Last Updated
May 25, 2021
Record last verified: 2021-05